Financial Health Assessment: HARNEL GROUP LTD

1. Financial Health Score: F

Explanation: The patient is in critical condition. HARNEL GROUP LTD is suffering from chronic insolvency, meaning its liabilities consistently exceed its assets. With negative net assets of -£13,690 and an almost non-existent liquidity ratio, the business is technically insolvent and surviving only on life support—likely the continued forbearance of its creditors.

2. Key Vital Signs

• Net Assets (Shareholders' Funds): -£13,690 (down from -£7,205 in 2023)
  • Interpretation: This is a chronic illness. A negative net asset position means the company owes more than it owns. This has been a persistent issue since 2017, indicating a long-term structural imbalance rather than a temporary setback.
• Current Assets: £2,155 (down from £22,312 in 2023)
  • Interpretation: The company's "blood flow" (cash and short-term assets) has severely depleted by over 90% in one year. This represents an acute symptom of distress, leaving the business with virtually no resources to operate.
• Current Liabilities: £15,845 (down from £29,517 in 2023)
  • Interpretation: While a reduction in debt is generally positive, the fact that liabilities still dwarf assets by a ratio of more than 7:1 means the company remains in a dangerously leveraged position.
• Liquidity Ratio: 0.13 (£2,155 / £15,845)
  • Interpretation: A healthy ratio is typically above 1.0. At 0.13, for every £1 the company owes in the next 12 months, it only has 13p to pay it. This indicates extreme short-term vulnerability.
• Operational Pulse (Employees): 0
  • Interpretation: The company has zero employees, suggesting it is either dormant, operating as a shell, or relying entirely on the unpaid directorship of Mr. Daniel Nelson. There is no operational metabolism to generate organic recovery.

3. Diagnosis

The financial data reveals a business suffering from chronic balance sheet insolvency compounded by an acute liquidity crisis.

Looking at the medical history, the company has carried negative equity since at least 2017. The "tumor" of debt has fluctuated over the years, but the patient has never achieved remission (a positive net asset position). In the latest fiscal year (2024), the company suffered a severe hemorrhage of current assets, dropping from £22k to just £2k. While some liabilities were paid off (dropping from £29k to £15k), the asset depletion outpaced the debt reduction, driving the net asset position further into negative territory.

Because current liabilities significantly exceed current assets, the company is entirely dependent on the willingness of its creditors (who, given the structure, may include the directors or related parties) not to demand repayment. Without this "life support," the company would face immediate failure. The lack of employees and minimal share capital (£2) suggest this entity may be operating as a holding company or a dormant vehicle for specific activities, but even by those standards, the financial vitals are dangerously weak.

4. Recommendations

To stabilize the patient and prevent terminal decline, the following immediate interventions are required:

1. Emergency Capital Transfusion: The company requires an immediate injection of capital to correct the negative equity. This should be done via a capital contribution or the issuance of new shares rather than taking on more debt, which would only worsen the liquidity strain.
2. Debt Forgiveness/Surgery: If a significant portion of the £15,845 in current liabilities is owed to the directors (Mr. Nelson or Mr. Harverson), they should consider formally forgiving the debt or converting it into equity. This "surgical removal" of debt would immediately improve the net asset position and reduce the pressure on cash flow.
3. Viability Review: A thorough examination is needed to determine if the company has a viable business model. With zero employees and vanishing assets, the purpose of maintaining this entity must be questioned. If it is no longer serving a strategic purpose, the most responsible treatment may be to wind up operations voluntarily before the financial health deteriorates further.
4. Cash Flow Stabilization: Until the balance sheet is repaired, the company must strictly limit any new expenditures and avoid taking on new liabilities that it cannot immediately cover with its current asset base.